Legend Biotech Corporation
LEGN
$27.75
$1.063.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.69M | -125.38M | -100.92M | 26.28M | -125.32M |
| Total Depreciation and Amortization | 5.88M | 5.85M | 5.20M | 6.59M | 3.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | 206.00K | -- |
| Total Other Non-Cash Items | 15.41M | 142.08M | 65.55M | -35.08M | 81.19M |
| Change in Net Operating Assets | 47.21M | -35.59M | -73.59M | -80.08M | -35.60M |
| Cash from Operations | 28.80M | -13.04M | -103.75M | -82.08M | -75.82M |
| Capital Expenditure | -5.01M | -9.22M | -2.00M | -2.38M | -2.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -156.30M | 258.64M | -85.46M | 331.14M |
| Cash from Investing | -20.00M | -165.53M | 256.64M | -87.84M | 329.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -602.00K | -1.26M | -777.00K | -936.00K | -1.16M |
| Issuance of Common Stock | 1.27M | 273.00K | 1.44M | 603.00K | 5.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 670.00K | -990.00K | 667.00K | -333.00K | 4.25M |
| Foreign Exchange rate Adjustments | 2.84M | 4.44M | 1.40M | -2.28M | 524.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.31M | -175.12M | 154.95M | -172.53M | 258.02M |